Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
This is in response to the Amendment dated September 17, 2026. The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office Action.
Response to Amendment
Election/Restrictions
This application contains claims 1 (product) and 2-6 (composition) drawn to an invention nonelected without traverse in the reply filed on June 1, 2026.
Priority
Acknowledgment is made of applicant's claim for foreign priority based on an application filed in China on December 30, 2024. It is noted, however, that applicant has not filed a certified copy of the 202411964288.4 application as required by 37 CFR 1.55.
Claim Objections
Claim 7 has been objected to because of minor informalities.
The objection of claim 7 has been withdrawn in view of Applicant’s amendment.
Claim Rejections - 35 USC § 103
I. Claim(s) 7 and 8 have been rejected under 35 U.S.C. 103 as being unpatentable over WO 2021/198429 (‘429) in view of CN 215103561 (‘561), WO 2017/205473 (‘473), CN 115522239 (‘239) and CN 201850322 (‘322).
The rejection of claims 7 and 8 under 35 U.S.C. 103 as being unpatentable over WO 2021/198429 (‘429) in view of CN 215103561 (‘561), WO 2017/205473 (‘473), CN 115522239 (‘239) and CN 201850322 (‘322) has been withdrawn in view of Applicant’s remarks.
II. Claim(s) 9 has been rejected under 35 U.S.C. 103 as being unpatentable over WO 2021/198429 (‘429) in view of CN 215103561 (‘561), WO 2017/205473 (‘473), CN 115522239 (‘239) and CN 201850322 (‘322) as applied to claims 7 and 8 above, and further in view of CN 105220190 (‘190).
The rejection of claim 9 under 35 U.S.C. 103 as being unpatentable over WO 2021/198429 (‘429) in view of CN 215103561 (‘561), WO 2017/205473 (‘473), CN 115522239 (‘239) and CN 201850322 (‘322) as applied to claims 7 and 8 above, and further in view of CN 105220190 (‘190) has been withdrawn in view of Applicant’s remarks.
III. Claim(s) 10 has been rejected under 35 U.S.C. 103 as being unpatentable over WO 2021/198429 (‘429) in view of CN 215103561 (‘561), WO 2017/205473 (‘473), CN 115522239 (‘239) and CN 201850322 (‘322) as applied to claims 7 and 8 above, and further in view of Rudy (“Analysis, Observation, and Maintenance of Finishing Baths,” Plating, 17 November 2023, pp.
1-3).
The rejection of claim 10 under 35 U.S.C. 103 as being unpatentable over WO 2021/198429 (‘429) in view of CN 215103561 (‘561), WO 2017/205473 (‘473), CN 115522239 (‘239) and CN 201850322 (‘322) as applied to claims 7 and 8 above, and further in view of Rudy has been withdrawn in view of Applicant’s remarks.
Continued Response
Claim Objections
Claims 7-8 and 10 are objected to because of the following informalities:
Claim 7
Line 26, please amend “a plating bath” to -- the potassium chloride-based zinc-iron alloy plating solution --.
This is an instance where the article should be changed to ensure proper antecedent basis for the claim terminology.
Claim 8
Line 1, phrase insert the phrase -- used in the electroplating -- after the word “anode”.
This is an instance where the article should be added to ensure a relationship between the claim terminology.
Claim 10
Line 2, please amend “the plating bath” to -- the potassium chloride-based zinc-iron alloy plating solution --.
This is an instance where the article should be changed to ensure proper antecedent basis for the claim terminology.
Claim Rejections - 35 USC § 112
Claims 7-11 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention.
Claim 7
Lines 26-27, recite “a cathode”.
Claim 7, lines 4-5, recite “electroplating zinc-iron alloy on the preprocessed workpiece to give an electroplated workpiece”.
Since the preprocessed workpiece is electroplated, it appears that the preprocessed workpiece would have been the cathode. However, the claim language is unclear as to whether it is.
See also claim 7, line 27; and claim 9, line 2.
Claim 10
Lines 2-3, “during production” lacks antecedent basis.
Furthermore, it is unclear from the claim language that when ferrous sulfate heptahydrate is selected1 how this limitation further limits the method of claim 7.
Appropriate correction is required.
Allowable Subject Matter
The following is a statement of reasons for the indication of allowable subject matter:
Claims 7-11 define over the prior art of record because the prior art does not contain any language that teaches or suggests a zinc-iron electroplating method comprising the steps of preparing, preprocessing, electroplating, subjecting and sealing as presently claimed, esp., wherein the complexing agent comprises a component A and a component B; the component A is selected from the group consisting of sodium gluconate, sodium glucoheptonate, potassium sodium tartrate, sodium citrate and a combination thereof; the component B is sodium sulfosalicylate; and the component A and the component B are mixed according to a weight ratio of 3: 1-3. Therefore, a person skilled in the art would not have been motivated to adopt the above conditions, and a prima facie case of obviousness cannot be established.
CN 215103561 and WO 2017/205473 do not teach wherein the complexing agent comprises a component A and a component B; the component A is selected from the group consisting of sodium gluconate, sodium glucoheptonate, potassium sodium tartrate, sodium
citrate and a combination thereof; the component B is sodium sulfosalicylate; and the component A and the component B are mixed according to a weight ratio of 3: 1-3.
Claims 7-8 and 10 would be allowable if rewritten or amended to overcome the claim objection(s) set forth in this Office action.
Claims 7-11 would be allowable if rewritten or amended to overcome the rejection(s)
under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action.
THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a).
A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to EDNA WONG whose telephone number is (571) 272-1349. The examiner can normally be reached Monday-Friday, 7:00 AM- 3:30 PM.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s
supervisor, Luan Van can be reached at (571) 272-8521. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/EDNA WONG/Primary Examiner, Art Unit 1795
1 Claim 7, lines 12-13, recite “2-12 g/L of ferrous chloride tetrahydrate or 3-17 g/L of ferrous sulfate heptahydrate”.